NextPlat (NASDAQ:NXPL) Shares Scheduled to Reverse Split on Monday, April 6th

NextPlat Corp. (NASDAQ:NXPL)’s stock is scheduled to reverse split on Monday, April 6th. The 1-10 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the market closes on Sunday, April 5th.

NextPlat Stock Performance

NASDAQ:NXPL opened at $0.39 on Thursday. The company has a quick ratio of 2.80, a current ratio of 3.56 and a debt-to-equity ratio of 0.04. NextPlat has a twelve month low of $0.34 and a twelve month high of $1.11. The company has a fifty day moving average of $0.54 and a 200-day moving average of $0.65. The firm has a market capitalization of $10.57 million, a P/E ratio of -0.89 and a beta of 1.38.

NextPlat (NASDAQ:NXPL) last issued its earnings results on Tuesday, March 31st. The company reported ($0.24) earnings per share (EPS) for the quarter. The company had revenue of $12.81 million for the quarter. NextPlat had a negative return on equity of 34.22% and a negative net margin of 14.58%.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of NextPlat in a research report on Monday, December 22nd. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock has a consensus rating of “Sell”.

Hedge Funds Weigh In On NextPlat

A hedge fund recently bought a new stake in NextPlat stock. Citadel Advisors LLC purchased a new stake in shares of NextPlat Corp. (NASDAQ:NXPL) in the third quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned approximately 0.19% of NextPlat at the end of the most recent quarter. 1.30% of the stock is currently owned by institutional investors and hedge funds.

About NextPlat

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.